A new survey indicates that improved quality of care for children of colour will be achieved only by an increased focus on particular...

Patients with moderate-to-severe hidradenitis suppurativa (HS) who are being treated with adalimumab do not need to stop the medication...

New research has suggested that the levels of interferon kappa, a skin protein, may be linked to the severity of psoriasis.

A validation study published in the International Journal of Dermatology (2021; 60:851–856) outlines how a new test for melanoma could...

Early research suggests that two hydrogen sulphide-producing medications could help prevent sun-related skin aging. In a press release...

A recent evaluation of studies on the risk of Covid-19 in patients with psoriasis and psoriatic arthritis has suggested a high risk of bias.

Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...

Findings from a systematic review of the accuracy of the individual structures and patterns used in dermoscopy for melanoma detection...